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Chemical Structure, Reactivity, and
Carcinogenicity of Halohydrocarbons
by Benjamin L. Van Duuren*
This review summarizes studies concerning the covalent binding of [14C]TCE to rat liver microsomal
protein and exogenous DNA, in vitro, the enhancement of this binding by inducers of mixed-function
oxidases, and inhibition of binding by inhibitors of these enzymes. Furthermore, recent studies on this
type ofbinding in various strains ofmice and rats ofboth sexes and using microsomal preparations from
various organs are briefly reviewed. Other workreviewed here concernsthe synthesisofTCEepoxide and
its reaction with nucleophiles since it is believed that TCE epoxide is the activated carcinogenic inter-
mediate ofTCE. The utility of structural prognostication ofcarcinogenic activity and the importance of
considering possible metabolic pathways for other chlorinated olefins is also discussed.
Introduction
Since the time of the discovery of the car-
cinogenicity of vinyl chloride (VC) in laboratory
animals (1, 2) and humans (3) there has been an
extensive renewed interest in and researches on
halogenated hydrocarbons, both unsaturated and
saturated (4-6).
The carcinogenicity findings with VC led to
studies on its metabolism (7) and possible modes of
action (5, 8, 9). Simultaneously studies were under-
taken in a number of laboratories on other com-
pounds in this class, some of which are also being
examined in our laboratory.
Based on its chemical structure, reactivity and
possible metabolic pathways, we predicted that
trichloroethylene (TCE) will be carcinogenic, par-
ticularly to the liver (10, 11). Studies were per-
formed by us on the binding of [14C]TCE to rat
liver microsomal proteins in vitro (12, 13), as well as
the synthesis of the epoxide of TCE and its reac-
tions with nucleophilic trapping agents (14). More
recently, we have also completed studies on the
in vitro binding of ['4C]TCE to microsomal pro-
teins and to DNA in mice and rats ofvarious strains
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and both sexes and using microsomal preparations
from various organs (15).
The studies outlined in the previous paragraph,
as well as some as yet unpublished work from this
laboratory, will be briefly reviewed in this report.
Structural Prognostication of
Carcinogenicity
Past studies on structure-activity correlations in
this laboratory have dealt with direct-acting car-
cinogens of the epoxide (16) and halo ether (17, 18)
classes ofcompounds. Based on such studies it has
become possible, within specific classes of com-
pounds, to suggest the likelihood of carcinogenic-
ity. This subject was recently reviewed (11).
Moreover, this approach has important implica-
tions in occupational cancer and this aspect was
discussed at a recent symposium of the NationaJ
Academy of Sciences (19).
The same principles of structure-activity rela-
tionships apply also to indirect-acting carcinogens,
i.e., those which have to be metabolically activated
to carcinogenic intermediates. However, for these
compounds known or likely metabolic pathways for
activation and for detoxification need also to be
considered. This is, in fact, of overriding impor-
tance and some of these possible metabolic path-
ways will be discussed in a later section of this re-
port.
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This widely used industrial chemical and anesthet-
ic was chosen for the first phase of our work on
halogenated hydrocarbons because of its structural
analogy to VC and to some other known indirect-
acting carcinogens. TCE was also chosen after con-
sideration of its known and suggested metabolic
pathways.
Powell suggested many years ago (20) that TCE
(I) is probably metabolized to an epoxide,
epoxy-1,1,2-trichloroethane (II). This suggestion
was based on his extensive metabolic studies on
TCE. Subsequently, we suggested that VC (III)
exerts its carcinogenicity by metabolism to the acti-
vated carcinogenic intermediate (IV) i.e.,
chloroethylene epoxide (10). It was pointed out (10)
that IV is structurally analogous to the direct-acting
carcinogens bis(chloromethyl) ether (V) and
glycidaldehyde (VI). The chemistry and car-
cinogenicity of V and VI were described by us in
earlier research reports (16, 21-23).
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In the same report (14) we described the reaction
of II with a variety of nucleophiles shown in struc-
tures VII-XX. The purpose of these organic-
chemical studies was to obtain suitable agents for
intercepting the epoxide, if it were formed from
[14C] TCE, using in vitro biochemical experiments
with rat liver microsomal preparations. Because of
the high reactivity of the epoxide, II, it was impor-
tant that such intercepting nucleophilic reagents
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In a recent report the carcinogenicity assays on
TCE were described (24). The compound is car-
cinogenic to the liver by feeding to B6C3F1 hybrid
mice, but not to Osborne-Mendel rats. It should be
pointed out that TCE must be considered a weak
carcinogen because of the high dosages used in
these feeding experiments.
Moreover, there is a concern about the matter of
metabolic overload which may inactivate detoxify-
ing enzymes.
Epoxy-1,1,2-trichloroethane (II) was synthesized
by the autoxidation of TCE (I) with oxygen and
ultraviolet irradiation in the presence of benzoyl
peroxide. The product was fully characterized (14)
and it was found that the compound has ahalf-life of
react rapidly with II, have sufficient water
solubility; that the products couig be readily ex-
tracted by organic solvents from an aqueous sys-
tem, and that the nucleophiles selected are nontoxic
to the microsomal enzymes. All these criteria were
met by the nucleophiles and some of their products
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experiments are currently underway using
[14C]TCE with rat liver microsomal preparations
in vitro. For the determination of the covalent in-
teraction of TCE with rat liver microsomal pro-
teins, in vitro, microsomal preparations were ob-
tained using established procedures (25). The
[14C]TCE used was of > 99% radiochemical purity
as determined by gas chromatograph-mass spec-
trometry and was used as such.
These in vitro binding studies have been de-
scribed in detail by us (13). In brief, the studies
showed that TCE binds covalently to microsomal
proteins. The binding was decreased by
7,8-benzoflavone. This compound inhibits the bind-
ing of 7,12-dimethylbenz(a)anthracene to DNA,
RNA, and protein in mouse skin (26). The binding
ofTCE to rat liver microsomal protein was blocked
by ,B-diethylaminoethyl diphenylpropyl acetate
(SKF-525A), which is known to inhibit the
metabolism of various substrates of cytochrome
P-450 (27). As expected, phenobarbital enhanced
the binding of TCE to microsomal proteins. Fi-
nally, the effect of an inhibitor of epoxide hydrase
(28), 1,2-epoxy-3,3,3-trichloropropane (TCPO) on
the same in lvitro system was examined and found to
cause an enhancement of TCE binding to mi-
crosomal protein. The addition of competing nu-
cleophiles such as reduced glutathione,
1-methyl-2-mercaptoimidazole, and mercap-
toethanol all decreased the binding of TCE to mi-
crosomal proteins.
All of these findings are consistent with the sug-
gestion that an epoxide intermediate is formed and
that such an epuxide may be the activated car-
cinogenic intermediate of TCE in liver car-
cinogenesis.
The likely metabolit pathway ofTCE in animals
and man is summarized in the scheme involving
structures I, 11, and XXI-XXIV which is consis-
tent with the metabolic studies and the suggestion
of Powell (20) concerning an epoxide intermediate.
In recent experiments (15, 30), the binding of
TCE to liver microsomal proteins of male B6C3F1
hybrid mice which are susceptible to TCE-induced
liver tumorigenesis (24) was found to be signifi-
cantly higher than the binding of ['4C]TCE to mi-
crosomal protein from male Osborne-Mendel rats,
which were resistant to TCE-induced hepatocellu-
lar carcinoma in the same earlier study (24). The in
vitro binding of [14C]TCE to liver microsomal pro-
teins was higher for male compared with female
B6C3F1 mice; females have been reported (24) to
show a lower incidence ofTCE-induced hepatocel-
lular carcinoma compared with males. Microsomal
proteins from the lung, stomach, and kidney of
Metabolism of Trichloroethylene in Animals and Man
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B6C3F I hybrid mice also metabolized TCE as indi-
cated by the covalent binding of [14C]TCE to mi-
crosomal protein from these organs.
Incubation of [14C]TCE with salmon sperm
DNA in the presence of microsomal preparations
from B6C3FI hybrid mice resulted in covalent bind-
ing of [14C]TCE to DNA. This binding was much
higher in the presence of microsomal proteins from
male compared with female mice. The binding to
DNA and protein was enhanced by in Oi'o
phenobarbital administration. These findings are
described in detail in a recent report from this
laboratory (15).
It should be noted that since the announcement
of the carcinogenicity of TCE by the National
Cancer Institute (29), a number of substitutes for
TCE have been introduced in industry. Some of
these compounds are listed in Table 1. These com-
pounds have not undergone chronic bioassay for
carcinogenicity. Hence their use as substitutes is
regrettable since all four are expected to cause liver
damage, and compounds XXVI and XXVII are in
all likelihood also liver carcinogens.
Table 1. Substitutes for trichloroethylene in degreasing,
manufacture of decaffeinated coffee, and other uses.
Structure Name
Cl3C-CH3 XXV 1,1,l-Trichloroethane
CH2CI2 XXVI Dichloromethane
C12C=-CC12 XXVII Tetrachloroethylene
Cl 3C-C Cl 3 XXVIII Hexachloroethane
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Carcinogenicity Assays of Vinyl
Bromide and Poly(vinyl Bromide)
Poly(vinyl bromide) (PVBr) and copolymers con-
taining the vinyl bromide (VBr) moiety have been
under investigation for possible use as flame retar-
dants.
Because of our continuing interest in flame retar-
dants (31) and because ofthe structural closeness of
vinyl chloride and VBr, the latter compound and its
polymer were tested for carcinogenicity in mice.
(Both materials were kindly provided by Ethyl
Corporation, Detroit, Mich.) The results of these
experiments are given in detail in Tables 2 and 3,
since they have not been published elsewhere.
Skin application of VBr in acetone solution and
PVBr in commercial aqueous latex suspension
using female ICR/Ha Swiss mice, 30 per group, did
not result in any skin tumors in either group. When
tested as initiators with phorbol myristate acetate
(PMA) as promoter (two-stage carcinogenesis), the
test group (VBr followed by PMA) did not show
any significant increase in tumors induced com-
pared with the control group (PMA alone). The
Table 2. Carcinogenicity ofvinyl bromide and poly(vinylbromide) tested as initiators and whole carcinogens on mouse skin.a.b
Initiator and dose, Days to Number of mice with papillomasc
mg/0.1 ml acetone first
(except where noted) tumor Total number of papillomas
Vinyl bromide, 15.0 412 lld
Polyvinyl bromide 175 1/1
(0.1 ml commercial
suspension)
DMBA, 0.02 (positive control) 62 30/320 (19)
PMA (control) 44 1 (1)
No treatment (160 mice) 0
aThirty female ICR/Ha Swiss mice per group; duration 420 days; PMA 2.5 jig, three times/week.
bBoth compounds were completely inactive when tested as whole carcinogens on mouse skin by repeated application,
3 x wkly at the same doses and group sizes given above, also for 420 days.
cNumber of mice with squamous carcinoma in parentheses.
dOne additional animal bore a subcutaneous fibrosarcoma.
Table 3. Carcinogenicity ofvinyl bromide and poly(vinyl
bromide): subcutaneous injection in mice.a
Compound and dose Number of mice with
(once per week) local tumors
Vinyl bromide, 25 mg/0.05 ml 0
trioctanoin
Polyvinyl bromide, 0.05 ml 19 liposarcomasb
commercial suspension
,B-Propiolactone, 0.3 mg/0.05 ml 18 sarcomas
trioctanoin (positive control) 3 squamous
carcinomas
Trioctanoin only, 0.05 ml 0
No treatment (60 mice) 0
aThirty female ICRIHa Swiss mice per group; duration 420
days.
bDiscontinued treatment after 48 treatments.
positive control group showed the expected high
tumor incidence (32). Although VBr has a low boil-
ing point (15.80C/760 mm), it is expected that the
high dose used in the skin application experiments,
15 mg/application in 0.1 ml acetone, would result in
absorption into the skin of a substantial amount of
the material before evaporation.
The two materials were also tested by sub-
cutaneous injection in mice (Table 3); VBr was in-
active. PVBr, on the other hand, resulted in a high
incidence of liposarcomas. However, the material
was injected as an aqueous suspension and hence
this interesting finding probably is due to physical
carcinogenesis and thus does not bear on the matter
of VBr and/or PVBr as chemical carcinogens. To
our knowledge inhalation studies on VBr have not,
as yet, been reported.
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The results ofthese tests are incomplete and will be
published elsewhere when the histopathology is
complete.
Other Chlorinated Hydrocarbons
Because of the extensive use of chlorinated hy-
drocarbons in chemical industry, some of them are
becoming ubiquitous environmental contaminants
and possibly environmental hazards. They may
occur in films used as food wrappings, latex paint,
rubber, etc. (4-6) and some ofthem occur in drink-
ing water. A few ofthe compounds ofconcern to us
that have been shown to occur in drinking water
(33) are listed in Table 4. The presence of these
compounds in drinking water must be ascribed to
contamination of water supplies by effluents from
chemical industry. The carcinogen chloroform (34,
35) also occurs in drinking water. However, this
compound is also produced from naturally occur-
ring humic materials in the disinfection of water
supplies by chlorine (36, 37). The latter source must
account, at least in part, for its presence in drinking
water.
Table 4. Some chloroolefins in drinking water.a
Name Structure
Vinyl chloride III CH2=CHCI
Vinylidene chloride XXIX CH2=CCl2
1,2-Dichloroethylene XXX ClCH=CHCl
(cis and trans)
1,1,2-Trichloroethylene I C12C=CHCI
Tetrachloroethylene XXVII Cl2C=CC12
Hexachlorobutadiene XXXI Cl2C=- C=CC12
Cl Cl
I-Chloropropene-l XXXII H-C CH-CH3
Cl
aEPA data (33).
The manufacture, chemistry and toxicology of
these compounds have been reviewed recently (38).
The purpose ofthis section of the present review is
to discuss some compounds which are of current
interest and under investigation in many
laboratories, including our own.
The compounds of major interest are shown in
structures XXVII, XXIX, XXXI, and
XXXIII-XXXVIII. These compounds merit spe-
cial attention for several reasons: (a) the structural
analogy of some of these compounds (the chlori-
nated olefins) to vinyl chloride and TCE and hence
possible carcinogenicity; (b) their large-scale pro-
duction and use in chemical industry leading to en-
vironmental pollution by these agents; (c) some of
these compounds are known carcinogens in ro-
dents, e.g. ethylene dibromide (39), hexach-
lorobutadiene (40), and vinylidene chloride (41).
Hexachlorobutadiene was recently shown to cause
kidney tumors in rats by ingestion, but details of
these experiments are not, as yet, available.
Ethylene dichloride is discussed elsewhere in this
volume (42).
Studies in this laboratory on structures XXVII,
XXIX, XXXI and XXIII-XXXVIII are con-
cerned with their chemistry, metabolism, car-
cinogenicity and determination of the nature of the
activated carcinogenic intermediates for those
compounds which are known carcinogens. These
studies are carried out by using the same ap-
proaches described earlier in this review for tri-
chloroethylene, and also including bioassays.
In conclusion, only one additional point will be
made, and that concerns the matter of structural
prognostication of carcinogenicity already alluded
to in an earlier section of this review. For com-
pounds suspected to be carcinogenic, it is ofimpor-
tance to examine the known, as well as postulated
metabolic pathways ifit appears likely that the par-
ent compound is an indirect-acting carcinogen. As
CH =CHCH2OH - CH =CHCHO -) CH2=CHCO2H 2 2 ~~~~~22 2
CH =CHCH2Cl 2 2
Allyl chloride
XXXIII
XXXIX
0\
CHi-CHCH2C1 -
XL XLI
0 0 0
CHz-CHCH2OH CH2-CHCHO - CH7CHC02H
Epichlorhydrin
(Carcinogenic)
XLII
Glycidol
XLIII
Glycidaldehyde Epoxypropionic acid
(Carcinogenic)
VI XLIV
December 1977 21an example, the possible intermediates that can be
visualized for the metabolism of allyl chloride,
XXXIII are shown in structures VI and
XXXIX-XLIV. This example is particularly in-
teresting, since two of the possible intermediates,
epichlorhydrin (XLII) and glycidaldehyde (VI) are
known direct-acting carcinogens (17, 43).
The author is indebted to his collaborators whose work is
summarized as part of this review and referred to in the refer-
ences. They are: S. Banerjee, B. M. Goldschmidt, S. A. Kline,
G. Loewengart, S. Melchionne and A. Smith.
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